AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-2065634_ITM" title="Facts and information about InSync Cardiac Resynchronization Therapy (CRT) Device. (New & Approved: Natrecor * InSync Cardiac Resynchronization Therapy * Topamax).">InSync Cardiac Resynchronization Therapy (CRT) Device. (New & Approved: Natrecor * InSync Cardiac Resynchronization Therapy * Topamax).</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
InSync Cardiac Resynchronization Therapy (CRT) Device. (New & Approved: Natrecor * InSync Cardiac Resynchronization Therapy * Topamax).
(Medtronic Inc.)
An implantable pacing device for resynchronizing the heart in patients with advanced CHF, the first pacemaker approved to treat CHF symptoms.
Usage: A small pulse generator implanted below the shoulder is attached to three pacing leads that deliver electrical impulses to the right atrium and each ventricle, providing simultaneous biventricular pacing. Special Considerations: Implanting the device is technically challenging and requires special training. Only patients not helped by drug treatment are candidates, the Food and Drug ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Medtronic launches InSync cardiac resynchronization therapy system in Japan.
- Newspaper article from: Biotech Week June 23, 2004 700+ words
...has launched its InSync cardiac resynchronization therapy (CRT) system in...acceptance of cardiac resynchronization therapy by the global medical...introduced cardiac resynchronization therapy in Europe in 1998...
- Medtronic's InSync Cardiac Resynchronization Therapy Device Approved by FDA;...
- Press release article from: Business Wire August 28, 2001 700+ words
...ventricles. InSync cardiac resynchronization therapy is the first...population. "The InSync cardiac resynchronization...Cardiac resynchronization therapy will benefit...The Medtronic InSync cardiac resynchronization...
- Newstream.com Digest: FDA Approves Medtronic's InSync Cardiac Resynchronization...
- Press release article from: Business Wire August 28, 2001 700+ words
...Medtronic's InSync(R) Cardiac Resynchronization Therapy Device Approved by FDA Medtronic Inc...Administration has approved its InSync(R) cardiac resynchronization therapy, the first major therapeutic breakthrough...
- ADVISORY/Medtronic's InSync Cardiac Resynchronization Therapy Device Approved...
- Press release article from: Business Wire August 28, 2001 700+ words
...on Aug. 28, 2001, that the U.S. Food and Drug Administration has approved its InSync(R) cardiac resynchronization therapy, the first major therapeutic breakthrough for heart failure since the development of specialized heart failure...
- Medtronic Launches InSync Cardiac Resynchronization Therapy System in Japan.
- Press release article from: Business Wire May 28, 2004 700+ words
...launched the InSync(R) cardiac resynchronization therapy system in Japan, bringing an...only company offering cardiac resynchronization therapy to patients with heart failure...The rapid acceptance of cardiac resynchronization therapy by the global medical community...
- Natrecor. (New & Approved: Natrecor * InSync Cardiac Resynchronization Therapy...
- Magazine article from: OB GYN News Mechcatie, Elizabeth October 15, 2001 700+ words
(nesiritide, Scios Inc.) A recombinant form of human B-type natriuretic peptide (hBNP) for people with acutely decompensated congestive heart failure (CHF), with shortness of breath at rest or with minimal activity. This is the first new treatment approved for decompensated CHF in more than a
- Topamax. (New & Approved: Natrecor * InSync Cardiac Resynchronization Therapy *...
- Magazine article from: OB GYN News Mechcatie, Elizabeth October 15, 2001 700+ words
(topiramate, Ortho-McNeil Pharmaceutical Inc.) An anticonvulsant for add-on therapy in people aged 2 and older with seizures related to Lennox-Gastaut syndrome, the third anticonvulsant approved for this devastating form of epilepsy Previously approved as adjunctive therapy for partial-onset
- InSync Cardiac Resynchronization Therapy (CRT) Device.(Brief Article)
- Magazine article from: Internal Medicine News Mechcatie, Elizabeth October 15, 2001 700+ words
(Medtronic Inc.) An implantable pacing device for resynchronizing the heart in patients with advanced CHF, the first pacemaker approved to treat CHF symptoms. * Usage: A small pulse generator implanted below the shoulder is attached to three leads that deliver electrical impulses to the right
